Immune to Cancer: The CRI Blog
-
CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide
A Large Cancer Presence on a Global Scale The Cancer Research Institute (CRI) has a singular focus:… -
How CRI is Taking on Pancreatic Cancer, “The Silent Killer”
Immunotherapy holds the greatest promise for optimizing outcomes for cancer patients, and eventually finding a cure for… -
This is How CRI Funded Scientists are Fighting Breast Cancer
A Global Challenge Breast cancer poses a formidable challenge to healthcare, being one of the most common… -
Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field
iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill… -
<strong><u>AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy</u></strong>
More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR… -
<strong>A Conversation with CRI ImmunoAdvocate Karen Peterson</strong>
Karen Peterson shares her journey from an immunotherapy clinical trial to patient advocate working to improve clinical… -
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm
In 2017, I was diagnosed with stage four triple-negative breast cancer (TNBC), one of the most aggressive… -
5 Things Patients, Caregivers, and Families Need to Know About Cancer
Our CEO speaks with Medium/Authority Magazine about cancer, immunotherapy, and how she became CEO of the world’s… -
ASCO 2022 Recap: Cancer Immunotherapy Updates
Since the first FDA approval in 2011 to treat cancer patients with checkpoint immunotherapy, doctors have sought…